CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine.
Karantanos T, Teodorescu P, Arvanitis M, Perkins B, Jain T, DeZern AE, Dalton WB, Christodoulou I, Paun BC, Varadhan R, Esteb C, Rajkhowa T, Bonifant C, Gondek LP, Levis MJ, Yegnasubramanian S, Ghiaur G, Jones RJ.
Karantanos T, et al. Among authors: paun bc.
Haematologica. 2023 Jul 1;108(7):1886-1899. doi: 10.3324/haematol.2022.281444.
Haematologica. 2023.
PMID: 36519323
Free PMC article.